30
Thu, May
59 New Articles

B2RLaw Advises on KnowledgeHub's Investment in Genomtec

B2RLaw Advises on KnowledgeHub's Investment in Genomtec

Poland
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

B2RLaw has advised KnowledgeHub on its EUR 1 million investment in Genomtec. Solo practitioner Jakub Kapica advised Genomtec on the deal.

KnowledgeHub is a venture capital fund supporting start-ups with global development potential. KnowledgeHub focuses on investments in martech, fintech, medtech, and deeptech start-ups.

Genomtec, which is based in Poland, is described by B2RLaw as a “medical technology company focused on developing and commercializing a mobile platform used in the molecular clinical diagnosis of various infectious diseases, including tests used to detect COVID-19 caused by SARS-CoV-2.” According to the firm, “the company’s flagship project is the mobile genetic diagnostics system, Genomtec ID. The system allows for quick and precise molecular analysis outside a laboratory environment, without the involvement of qualified laboratory personnel.”

B2RLaw’s team consisted of Partners Szymon Syp and Przemyslaw Krzemieniecki and Senior Associate Iga Wojtczak-Opala.

Our Latest Issue